机构：[1]Oncology, Department of oncology, Puer People’s hospital, Yunnan, Puer, China[2]Medical department, The Medical Department, 3D Medicines Inc., Shanghai, 201114, PR China, Shanghai, China[3]Department of thoracic surgery, Department of thoracic surgery, Yan’an Affiliated Hospital of Kunming Medical University, Kunming, China[4]Oncology, Department of oncology, yunnan hospital of traditional Chinese medicine, Kunming, China[5]Department of thoracic surgery, Department of thoracic surgery, yunnan first people’s hospital, Kunming, China外科片胸外科云南省第一人民医院[6]Oncology, Department of Oncology, Yan’an Affiliated Hospital of Kunming Medical University, Kunming, China
第一作者机构：[1]Oncology, Department of oncology, Puer People’s hospital, Yunnan, Puer, China
推荐引用方式(GB/T 7714)：
Yang B.,Zhang H.,Yang W.,et al.Immune microenvironment could be responsible for response to immune checkpoint inhibitors among NSCLC patients with various EGFR mutation types[J].ANNALS OF ONCOLOGY.2020,31:S889-S889.doi:10.1016/j.annonc.2020.08.1718.
APA：
Yang, B.,Zhang, H.,Yang, W.,Li, D.,Li, Y....&Wang, Y..(2020).Immune microenvironment could be responsible for response to immune checkpoint inhibitors among NSCLC patients with various EGFR mutation types.ANNALS OF ONCOLOGY,31,
MLA：
Yang, B.,et al."Immune microenvironment could be responsible for response to immune checkpoint inhibitors among NSCLC patients with various EGFR mutation types".ANNALS OF ONCOLOGY 31.(2020):S889-S889
医学